Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures

Neurology

Volumn 67, Issue 10, 2006, Pages 1872-1875

  Marson, A G ^a,b   Williamson, P R ^a   Taylor, S ^a   Maguire, M ^a   Chadwick, D W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Clinical Sciences Centre for Research and Education   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEIZURE; THERAPY DELAY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGE OF ONSET; ANTICONVULSANTS; CARBAMAZEPINE; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 33845428511     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000244421.73986.09     Document Type: Article

References (10)

1. The National Collaborating Centre for Primary Care. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care - NICE guideline. London: National Institute for Clinical Excellence, 2004.
2. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs: I. Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1252-1260.
3. Leber P. Hazards of inference: the active control investigation. Epilepsia 1989;30 (suppl 1):S57-63.
4. Chadwick D, Privitera M. Placebo-controlled studies in neurology: where do they stop? Neurology 1999;52:682-685.
5. Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007-2013.
6. Brodie MJ, Wroe SJ, Dean ADP, Holdich TAH, Whitehead J, Stevens JW. Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 2002;3:140-146.
7. Chadwick DW, Anhut H, Greiner MJ, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998;51:1282-1288.
8. Sachdeo RC, Reife RA, Lim P, Pledger G. Topiramate monotherapy for partial onset seizures. Epilepsia 1997;38:294-300.
9. Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999;52:732-737.
10. Bergey GK, Morris HH, Rosenfeld W, et al. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89. Neurology 1997;49:739-745.